A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
出版年份 2023 全文链接
标题
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
作者
关键词
-
出版物
NATURE MEDICINE
Volume 29, Issue 4, Pages 906-916
出版商
Springer Science and Business Media LLC
发表日期
2023-03-14
DOI
10.1038/s41591-023-02234-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma
- (2022) Michael D. Jain et al. BLOOD
- Environmental factors shaping the gut microbiome in a Dutch population
- (2022) R. Gacesa et al. NATURE
- Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
- (2022) Melody Smith et al. NATURE MEDICINE
- Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
- (2022) Karla A. Lee et al. NATURE MEDICINE
- Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
- (2022) John A. McCulloch et al. NATURE MEDICINE
- Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
- (2022) Nazli Dizman et al. NATURE MEDICINE
- Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
- (2022) Leila Amini et al. Nature Reviews Clinical Oncology
- Akkermansia muciniphila phospholipid induces homeostatic immune responses
- (2022) Munhyung Bae et al. NATURE
- A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
- (2022) Emmanuel Bachy et al. NATURE MEDICINE
- Tumor interferon signaling and suppressive myeloid cells associate with CAR T cell failure in large B cell lymphoma
- (2021) Michael D. Jain et al. BLOOD
- Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
- (2021) Diwakar Davar et al. SCIENCE
- Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients
- (2021) Hasinika K. A. H. Gamage et al. Scientific Reports
- Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3
- (2021) Francesco Beghini et al. eLife
- Impact of Antibiotic Therapy and Metabolic Parameters in Non-Small Cell Lung Cancer Patients Receiving Checkpoint Inhibitors
- (2021) Angelo Castello et al. Journal of Clinical Medicine
- CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
- (2021) Vicki Plaks et al. BLOOD
- Microbiome and cancer
- (2021) Nyssa Cullin et al. CANCER CELL
- Gut-microbiota-targeted diets modulate human immune status
- (2021) Hannah C. Wastyk et al. CELL
- Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
- (2021) Maik Luu et al. Nature Communications
- Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
- (2020) Loretta J. Nastoupil et al. JOURNAL OF CLINICAL ONCOLOGY
- Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity
- (2020) Caron A. Jacobson et al. JOURNAL OF CLINICAL ONCOLOGY
- Gut microbiome, big data and machine learning to promote precision medicine for cancer
- (2020) Giovanni Cammarota et al. Nature Reviews Gastroenterology & Hepatology
- Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
- (2020) Lukas F. Mager et al. SCIENCE
- High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma
- (2020) Erin A. Dean et al. Blood Advances
- Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
- (2020) Qing Deng et al. NATURE MEDICINE
- The gut microbiota is associated with immune cell dynamics in humans
- (2020) Jonas Schluter et al. NATURE
- Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
- (2020) Erez N. Baruch et al. SCIENCE
- Naive T cell deficits at diagnosis and after chemotherapy impair cell therapy potential in pediatric cancers
- (2019) Rajat K Das et al. Cancer Discovery
- Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T-cells
- (2019) Philipp Karschnia et al. BLOOD
- CD19 CAR T cell product and disease attributes predict leukemia remission durability
- (2019) Olivia C. Finney et al. JOURNAL OF CLINICAL INVESTIGATION
- A Customized At-Home Stool Collection Protocol for Use in Microbiome Studies Conducted in Cancer Patient Populations
- (2019) Stephanie R. Hogue et al. MICROBIAL ECOLOGY
- Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia
- (2019) Jessica R Galloway-Peña et al. CLINICAL INFECTIOUS DISEASES
- Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
- (2019) David J. Pinato et al. JAMA Oncology
- Lactose drives Enterococcus expansion to promote graft-versus-host disease
- (2019) C. K. Stein-Thoeringer et al. SCIENCE
- Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
- (2018) L Derosa et al. ANNALS OF ONCOLOGY
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Emerging Cellular Therapies for Cancer
- (2018) Sonia Guedan et al. Annual Review of Immunology
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
- (2018) Frederick L Locke et al. LANCET ONCOLOGY
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation
- (2017) Jonathan U. Peled et al. JOURNAL OF CLINICAL ONCOLOGY
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice
- (2016) Yusuke Shono et al. Science Translational Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search